Whipple's disease endocarditis following anti-TNF therapy for atypical rheumatoid arthritis.
Ansemant
Thiphaine
T
Celard
Marie
M
Tavernier
Christian
C
Maillefert
Jean-Francis
JF
Delahaye
François
F
Ornetti
Paul
P
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001706:Biopsy; D004269:DNA, Bacterial / Q000032:analysis; D003937:Diagnosis, Differential; D004318:Doxycycline / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004386:Duodenum / Q000382:microbiology / Q000473:pathology; D004697:Endocarditis, Bacterial / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use; D016867:Immunocompromised Host; D008297:Male; D008875:Middle Aged; D010503:Periodic Acid-Schiff Reaction; D013585:Synovitis / Q000473:pathology; D054851:Tropheryma / Q000235:genetics / Q000302:isolation & purification; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D008061:Whipple Disease / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D014955:Wrist Joint / Q000473:pathology
D000900:Anti-Bacterial Agents; D018501:Antirheumatic Agents; D004269:DNA, Bacterial; D014409:Tumor Necrosis Factor-alpha; D006886:Hydroxychloroquine; D004318:Doxycycline